openPR Logo
Press release

Entry into the digitization-governed arena to be witnessed by the Immune Checkpoint Inhibitors Market from 2018-2028, reaching US$ 35 Bn

05-25-2022 09:40 AM CET | Health & Medicine

Press release from: Persistence Market Research

Entry into the digitization-governed arena to be witnessed

The Immune Checkpoint Inhibitors Market is expected to be worth US$ 35 Bn by the year 2028, at a CAGR of 14.6% between 2018-2028. Digital health is into occupation of a noteworthy position in our lives, thereby rendering it a significant tool in the medical device trends going forward. This would be the overall outlook of the healthcare vertical in the forecast period.

Attributed to growing demand for the development of biologics targeting cancer therapy, PMR predicts that the immune checkpoint inhibitors will present lucrative opportunities to investors in the near future - as quoted by a research expert at Persistence Market Research (Healthcare & Life Sciences).

Get Going With Sample Of Immune Checkpoint Inhibitors Market Report! https://www.persistencemarketresearch.com/samples/20122

Expanding at a booming CAGR of 14.6%, the global market for immune checkpoint inhibitors market is expected to reach a value beyond US$ 35 Bn over 2018-2026. The growing prevalence of various types of cancers and expanding healthcare expenditure will remain the most prominent drivers of the immune checkpoint inhibitors market over the forecast period.

Company Profiles:

AstraZeneca Plc.
Bristol-Myers Squibb Co.
Roche Holding AG
Incyte Corporation
Merck & Co., Inc.
Merck KGaA
Sanofi
Novartis AG

Besides cancer prevalence, increasing FDA approvals and growing use of immune-oncology products in treating cancers will also push the demand for immune checkpoint inhibitors in the near future. However, high price point associated with both drug development and treatment will continue to restrict adoption. Frequently observed last stage failure will also remain a major concern in the long run.

"Our extensive company share analysis predicts that the top two players in the global immune checkpoint inhibitors market currently hold a massive revenue share of over 95%. Based on the exhaustive assessment of each drug class in the global immune checkpoint inhibitors market, we arrived at the forecast that the PD-1 will continue dominance in the market, primarily attributed to rapid FDA approvals to PD-1 products," explained an expert senior research analyst working with the healthcare and life sciences domain at Persistence Market Research.

How About Re-Inventing The Methodical Wheel In The Immune Checkpoint Inhibitors Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/20122

FDA Approvals Continue to Encourage North American Market for Immune Checkpoint Inhibitors

North America is likely to continue monopoly in the global market for immune checkpoint inhibitors with over 65% share of the total market revenue. Large number of FDA approvals, expanding application base in treatments for various cancer types, and increasing combination drug approvals will play a pivotal role in shaping the market for immune checkpoint inhibitors in North America.

According to PMR's regional analysis of global immune checkpoint inhibitors market, Asia Pacific will demonstrate vigorous growth throughout the projection period - at the double digit CAGR of over 17%.

High Potential Combination Therapies to Open New Doors of Opportunities

With a strong reference post success of the promising results delivered by Bristol-Myers Squibb using a combination of Yervoy and Opdivo, the market for immune checkpoint inhibitors has been witnessing several more combination therapy products in the pipeline.

Keeping A Tab On Key Players In The Immune Checkpoint Inhibitors Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Immune Checkpoint Inhibitors Market Report! https://www.persistencemarketresearch.com/checkout/20122

Such a scenario is responsible for the current situation of the immune checkpoint inhibitors marketplace that reflects a major paradigm shift of companies from conventional mono-therapies to combination therapies for better end results. While a considerable number of combination therapies introduced by various companies have been successfully contributing to the efforts in transforming oncology, the global market for immune checkpoint expects successful introduction of more such therapies.

One of those in the pipeline includes the combination with target specific mAbs, chemotherapy, and other checkpoint inhibitors.

Key Players to Invest Efforts in Developing Products to Traverse Diverse Indications

The global immune checkpoint inhibitors market is competitive yet consolidated due to strong presence of established players; however, a few prominent brands such as Tecentriq have strategically maintained a consistent position in the market since their first product launch. A majority of leading players participating in the global immune checkpoint inhibitors marketplace are concentrating on incorporating value addition programs for regulating the customer base through enhancement of product offerings to suit a diverse range of indications.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/immune-checkpoint-inhibitors-market.asp

Established companies in the global immune checkpoint inhibitors market landscape are striving to enhance therapeutic applications of their existing product offerings. Moreover, a number of key players are also eyeing the high potential markets emerging in developing countries such as KSA and South Africa by seeking FDA approvals to their products in these markets.

Related Reports:

Non-invasive Prenatal Testing (NIPT) Market - https://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market.asp

Healthcare Clinical Analytics Market - https://www.persistencemarketresearch.com/market-research/healthcare-clinical-analytics-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Entry into the digitization-governed arena to be witnessed by the Immune Checkpoint Inhibitors Market from 2018-2028, reaching US$ 35 Bn here

News-ID: 2635558 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Immune

Immune Probiotic Supplement Market Reviews: What Works Best for Gut and Immune S …
The Global Immune Probiotic Supplement Market reached US$ 68.73 Billion in 2024 and is projected to witness lucrative growth by reaching up to US$ 133.08 Billion by 2032. The Global Immune Probiotic Supplement Market is expected to exhibit a CAGR of 8.61% during the forecast period 2024-2032. Immune Probiotic Supplement Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges.
Decoding the Immune System: Immune Repertoire Sequencing Market Unleashes Insigh …
The Immune Repertoire Sequencing Market is likely to grow voraciously, i.e. at a CAGR of 7.3% between 2018-2026. Augmented and virtual reality are abreast with advanced technologies on a significant count. VR and AR do have loads of potential for offering in the healthcare vertical. The application areas include surgery and training simulation, and patients care and treatment. Persistence Market Research (PMR) delivers the key insights on the immune repertoire sequencing
Immune health supplement Market - Guardian of health: Supporting immune strength …
Newark, New Castle, USA: The "Immune health supplement Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Immune health supplement Market: https://www.growthplusreports.com/report/immune-health-supplement-market/7978 This latest report researches the industry structure,
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts
Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an
Immune Health Supplements: Best Way to Boost Your Immune System
ResearchMoz include new market research report "Global Immune Health Supplements Market Research Report 2019" to its huge collection of research reports. Immune Health Supplements refer to the product which could improve human immune health. The global Immune Health Supplements market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. Learn more Through Sample Report